يعرض 1 - 10 نتائج من 33 نتيجة بحث عن '"De Placido S."', وقت الاستعلام: 1.92s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial

    المؤلفون: Piccirillo M. C., Avallone A., Carlomagno C., Maiello E., Rosati G., Alabiso O., Nasti G., De Placido S., Latiano T. P., Bilancia D., Ottaiano A., De Stefano A., Romano C., Silvestro L., Nappi A., Cassata A., Giordano P., Iaffaioli R. V., Normanno N., Perrone F., Daniele B.

    المساهمون: Piccirillo, M. C., Avallone, A., Carlomagno, C., Maiello, E., Rosati, G., Alabiso, O., Nasti, G., De Placido, S., Latiano, T. P., Bilancia, D., Ottaiano, A., De Stefano, A., Romano, C., Silvestro, L., Nappi, A., Cassata, A., Giordano, P., Iaffaioli, R. V., Normanno, N., Perrone, F., Daniele, B.

    مصطلحات موضوعية: Biomarker, EGFR, RAS, Resistance, Response

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000592967200024; volume:19; issue:4; firstpage:270; lastpage:276; numberofpages:7; journal:CLINICAL COLORECTAL CANCER; http://hdl.handle.net/11588/824201Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087495591

    الإتاحة: https://doi.org/10.1016/j.clcc.2020.05.009Test
    http://hdl.handle.net/11588/824201Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    مؤتمر
    Novel anticancer drugs TLR9 agonists interfere with EGFR signaling and potently synergies with EGFR inhibitors and with bevacizumab in wild type and cetuximab-resistant colon cancer xenografts

    المؤلفون: TORTORA, GIAMPAOLO, Caputo R., Bianco R., Garofalo S., Racioppi L., De Placido S., Ciardiello F., Agrawal S., Damiano V., MELISI, Davide

    المساهمون: Tortora, Giampaolo, Caputo, R., Bianco, R., Garofalo, S., Racioppi, L., De Placido, S., Ciardiello, F., Agrawal, S., Melisi, Davide, Damiano, V.

    مصطلحات موضوعية: TLR9, EGFR, bevacizumab

    العلاقة: Gastrointestinal Cancer Symposium 2007; numberofpages:1; http://hdl.handle.net/11562/434932Test

    الإتاحة: http://hdl.handle.net/11562/434932Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis

    المؤلفون: Damiano V, Rosa R, Formisano L, Nappi L, Gelardi T, Marciano R, Cozzolino I, Troncone G, Agrawal S, Veneziani BM, De Placido S, Bianco R, TORTORA, GIAMPAOLO

    المساهمون: Damiano, V, Rosa, R, Formisano, L, Nappi, L, Gelardi, T, Marciano, R, Cozzolino, I, Troncone, G, Agrawal, S, Veneziani, Bm, De Placido, S, Bianco, R, Tortora, Giampaolo

    مصطلحات موضوعية: Rapamycin, Toll-like receptor 9, EGFR

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23571736; info:eu-repo/semantics/altIdentifier/wos/WOS:000318406400009; volume:8; issue:108; firstpage:1616; lastpage:1623; numberofpages:8; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11562/566149Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84877018392

    الإتاحة: https://doi.org/10.1038/bjc.2013.153Test
    http://hdl.handle.net/11562/566149Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    مؤتمر
    Cooperative antitumor and antiangiogenic activity after oral administration of a novel taxane, an antisense targeting protein kinase A and the EGF receptor inhibitor Iressa

    المؤلفون: Damiano V., Caputo R., Fontanini G., Faviana P., De Placido S., Zunino F., Bianco A. R., Ciardiello F., TORTORA, GIAMPAOLO, MELISI, Davide

    المساهمون: Damiano, V., Caputo, R., Fontanini, G., Faviana, P., Melisi, Davide, De Placido, S., Zunino, F., Bianco, A. R., Ciardiello, F., Tortora, Giampaolo

    مصطلحات موضوعية: taxane, EGFR, PKA

    العلاقة: XXVIII Meeting of the Italian Cancer Society; numberofpages:2; journal:TUMORI; http://hdl.handle.net/11562/433968Test

    الإتاحة: http://hdl.handle.net/11562/433968Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Novel TLR9 agonist induces EGFR inhibition and synergistic antitumor activity with EGFR inhibitors.

    المؤلفون: DAMIANO V, CAPUTO R, BIANCO R, DARMIENTO F, LEONARDI A, DE PLACIDO S, BIANCO AR, AGRAWAL S, CIARDIELLO F, TORTORA, GIAMPAOLO

    المساهمون: Damiano, V, Caputo, R, Bianco, R, Darmiento, F, Leonardi, A, DE PLACIDO, S, Bianco, Ar, Agrawal, S, Ciardiello, F, Tortora, Giampaolo

    مصطلحات موضوعية: TLR9, EGFR, cetuximab

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/16428503; volume:12; firstpage:577; lastpage:583; numberofpages:6; journal:CLINICAL CANCER RESEARCH; http://hdl.handle.net/11562/346914Test

    الإتاحة: http://hdl.handle.net/11562/346914Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.

    المؤلفون: CIARDIELLO F, TROIANI T, CAPUTO F, DE LAURENTIIS M, PALMIERI G, DE VITA F, DIADEMA MR, ORDITURA M, COLANTUONI G, GRIDELLI C, CATALANO G, DE PLACIDO S, BIANCO AR, TORTORA, GIAMPAOLO

    المساهمون: Ciardiello, F, Troiani, T, Caputo, F, DE LAURENTIIS, M, Tortora, Giampaolo, Palmieri, G, DE VITA, F, Diadema, Mr, Orditura, M, Colantuoni, G, Gridelli, C, Catalano, G, DE PLACIDO, S, Bianco, Ar

    مصطلحات موضوعية: breast cancer, EGFR, gefitinib

    العلاقة: volume:94; firstpage:1604; lastpage:1609; numberofpages:6; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11562/346841Test

    الإتاحة: http://hdl.handle.net/11562/346841Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.

    المؤلفون: MELISI, Davide, CAPUTO R, DAMIANO V, BIANCO R, VENEZIANI BM, BIANCO AR, DE PLACIDO S, CIARDIELLO F, TORTORA, GIAMPAOLO

    المساهمون: Melisi, Davide, Caputo, R, Damiano, V, Bianco, R, Veneziani, Bm, Bianco, Ar, DE PLACIDO, S, Ciardiello, F, Tortora, Giampaolo

    مصطلحات موضوعية: Zoledronic acid, COX-2, EGFR

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/16322342; volume:12; firstpage:1051; lastpage:1058; numberofpages:8; journal:ENDOCRINE-RELATED CANCER; http://hdl.handle.net/11562/346850Test

    الإتاحة: http://hdl.handle.net/11562/346850Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER.

    المؤلفون: BIANCO R, CAPUTO R, DAMIANO V, DE PLACIDO S, FICORELLA C, AGRAWAL S, BIANCO AR, CIARDIELLO F, TORTORA, GIAMPAOLO

    المساهمون: Bianco, R, Caputo, R, Damiano, V, DE PLACIDO, S, Ficorella, C, Agrawal, S, Bianco, Ar, Ciardiello, F, Tortora, Giampaolo

    مصطلحات موضوعية: EGFR, mdm2, prostate cancer

    العلاقة: volume:10; firstpage:4858; lastpage:4864; numberofpages:7; journal:CLINICAL CANCER RESEARCH; http://hdl.handle.net/11562/346907Test

    الإتاحة: http://hdl.handle.net/11562/346907Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Combination of a selective cyclooxygenase-2 inhibitor with EGFR tyrosine kinase inhibitor ZD1839 (‘Iressa’) and Protein Kinase A antisense causes a cooperative antitumor and antiangiogenic effect

    المؤلفون: TORTORA, GIAMPAOLO, CAPUTO R, DAMIANO V, MELISI, Davide, BIANCO R, FONTANINI G, VENEZIANI BM, DE PLACIDO S, BIANCO AR, CIARDIELLO F.

    المساهمون: Tortora, Giampaolo, Caputo, R, Damiano, V, Melisi, Davide, Bianco, R, Fontanini, G, Veneziani, Bm, DE PLACIDO, S, Bianco, Ar, Ciardiello, F.

    مصطلحات موضوعية: angiogenesi, EGFR, gefitinib

    العلاقة: firstpage:1231; lastpage:1232; numberofpages:2; journal:CLINICAL CANCER RESEARCH; http://hdl.handle.net/11562/346871Test

    الإتاحة: http://hdl.handle.net/11562/346871Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity

    المؤلفون: TORTORA, GIAMPAOLO, CAPUTO R, DAMIANO V, TROIANI T, VENEZIANI BM, DE PLACIDO S, BIANCO AR, ZANGEMEISTER WITTKE U, CIARDIELLO F.

    المساهمون: Tortora, Giampaolo, Caputo, R, Damiano, V, Troiani, T, Veneziani, Bm, DE PLACIDO, S, Bianco, Ar, ZANGEMEISTER WITTKE, U, Ciardiello, F.

    مصطلحات موضوعية: EGFR, Protein Kinase A, bcl-2

    العلاقة: firstpage:866; lastpage:871; numberofpages:6; journal:CLINICAL CANCER RESEARCH; http://hdl.handle.net/11562/346875Test

    الإتاحة: http://hdl.handle.net/11562/346875Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث